SPRUCE BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.708 USD | -0.28% |
|
+0.97% | -75.84% |
| Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
| Mar. 14 | Top Midday Decliners | MT |
Chart calendar Spruce Biosciences, Inc.
b3a.om14qB7-uYNIT6CyIe-O9wTd1GWXZBMcLLxyqScBCEI.xwpOmnm86NsRI_rKaNnttUa1giahBkZafdUa2xB1SjrkIxbKRKSKyyE64Q~df16ec6cdb8f3bf18e5068fd24c8dc76
Upcoming events on Spruce Biosciences, Inc.
Past events on Spruce Biosciences, Inc.
| 2024-03-13 04:30 pm | Tildacerfont CAHmelia-203 and CAHptain-205 Studies Results Call |
| 2024-03-13 04:08 pm | Q4 2023 Earnings Release |
| 2024-02-13 02:40 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-13 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-12 03:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-14 04:00 pm | Q2 2023 Earnings Release |
| 2023-06-17 02:00 pm | Endocrine Society Meeting |
| 2023-06-09 09:30 am | Jefferies Global Healthcare Conference |
| 2023-05-25 01:00 pm | Annual General Meeting |
| 2023-05-17 03:05 pm | RBC Global Healthcare Conference |
| 2023-05-15 01:30 pm | JMP Securities Life Sciences Conference |
| 2023-05-15 08:00 am | Q1 2023 Earnings Release |
| 2023-03-16 04:00 pm | Q4 2022 Earnings Release |
| 2023-03-14 02:40 pm | Oppenheimer Healthcare Conference |
| 2023-02-15 02:20 pm | SVB Securities Global Biopharma Conference |
| 2022-11-14 | Jefferies London Healthcare Conference |
| 2022-11-10 04:01 pm | Q3 2022 Earnings Release |
| 2022-11-08 05:35 pm | Credit Suisse Healthcare Conference |
| 2022-09-12 05:00 pm | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 10,1 8,53 18.28% | 4,60 |
|
EBITDA Million USD | Released Forecast Spread | -29,4 -36,0 18.39% | -42,0 -47,0 10.64% | -47,2 -46,0 -2.63% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -29,4 -34,2 13.86% | -42,1 -45,7 7.99% | -47,3 -47,6 0.57% | -52,0 -56,9 8.57% | -48,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,5 -35,5 16.79% | -42,3 -45,7 7.42% | -46,2 -47,3 2.35% | -47,9 -53,5 10.39% | -49,7 |
|
Net income Million USD | Released Forecast Spread | -29,5 -35,5 16.79% | -42,3 -45,7 7.49% | -46,2 -47,4 2.52% | -47,9 -53,6 10.65% | -49,8 |
|
EPS USD | Released Forecast Spread | -4,93 -5,07 2.76% | -1,81 -1,96 7.65% | -1,96 -2,01 2.57% | -1,24 -1,40 11.22% | -1,18 |
| Announcement Date | 22/03/21 | 14/03/22 | 16/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,96 5,25 -62.59% | 2,17 0,82 165.1% | 3,07 1,50 104.87% | 2,89 1,33 117.3% | 1,16 | 1,23 | 1,30 | 0,92 |
|
EBITDA Million USD | Released Forecast Spread | -9,12 -10,5 13.27% | -11,9 -10,7 -10.86% | -11,5 -10,6 -8.84% | -12,1 -9,60 -25.9% | |||||||||
|
EBIT Million USD | Released Forecast Spread | -9,14 -12,8 28.52% | -11,7 -10,9 -7.92% | -11,9 -12,3 3.28% | -11,6 -12,5 7.21% | -12,1 -12,4 2.21% | -13,2 -6,93 -90.42% | -14,0 -14,4 3.25% | -13,7 -14,5 5.84% | -11,2 -16,0 30.4% | -12,0 | -11,2 | -11,1 | -13,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,18 -12,5 26.59% | -11,8 -10,4 -13.26% | -11,9 -12,6 5.89% | -11,4 -12,7 10.52% | -11,1 -12,9 13.71% | -12,8 -3,40 -276.24% | -12,8 -13,4 4.35% | -12,4 -13,3 7.34% | -9,95 -15,6 36.33% | -11,6 | -10,9 | -10,8 | -16,5 |
|
Net income Million USD | Released Forecast Spread | -9,18 -12,6 26.88% | -11,8 -10,3 -13.89% | -11,9 -12,7 6.31% | -11,4 -12,7 10.04% | -11,1 -12,8 12.61% | -12,8 -7,16 -78.65% | -12,8 -14,3 10.04% | -12,4 -14,2 13.06% | -9,95 -15,7 36.76% | -12,4 | -11,7 | -11,6 | -14,1 |
|
EPS USD | Released Forecast Spread | -0,39 -0,54 27.33% | -0,50 -0,44 -13.64% | -0,51 -0,54 5.56% | -0,48 -0,54 10.78% | -0,47 -0,54 12.31% | -0,40 -0,20 -96.08% | -0,32 -0,39 18.37% | -0,30 -0,35 13.79% | -0,23 -0,39 40.52% | -0,31 | -0,29 | -0,27 | -0,33 |
| Announcement Date | 14/03/22 | 11/05/22 | 10/08/22 | 10/11/22 | 16/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 13/03/24 | - | - | - | - |
| Today 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| Today 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| Today 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
Past sector events for Spruce Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SPRB Stock
- Calendar Spruce Biosciences, Inc.
